Express News | Gilead : Leerink Partners Raises Target Price to $99 From $96

Reuters06:29 ET

Gilead Sciences' Strategic Focus on Lenacapavir and Lifecycle Management Drives Buy Rating

TipRanks06:07 ET · Ratings

BofA Securities Initiates Gilead Sciences(GILD.US) With Buy Rating, Announces Target Price $109

Moomoo News03:32 ET · Ratings

BofA Restarts Coverage of 11 Large-cap Biopharmas

Seeking Alpha17:01 ET

Unusual Options Activity: AI, MSTR and Others Attract Market Bets, AI V/OI Ratio Reaches 249.3

Moomoo News16:30 ET

Market Falls Wednesday, but Googles Chip Impresses | WST

Kevin Travers16:19 ET